370 filings
Page 7 of 19
8-K/A
0rg08
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
kdy7ju
9 Nov 20
Other Events
4:02pm
S-8
lei9i7
6 Nov 20
Registration of securities for employees
12:00am
S-8 POS
zw8vf3cqe8
5 Nov 20
Registration of securities for employees (post-effective amendment)
5:28pm
424B7
txude33pjnpxm00d
5 Nov 20
Prospectus with selling stockholder info
5:27pm
8-K
u5ca01 qx1vxfs
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
SEC STAFF
pk2chwxkxnzet50
30 Oct 20
SEC staff action: Order
12:00am
UPLOAD
f4zlprzxq35hsi532
30 Oct 20
Letter from SEC
12:00am
8-K/A
amgbbm0c
5 Oct 20
Submission of Matters to a Vote of Security Holders
4:21pm
8-K
1ibsoytyyc ko7
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
aghxgj02s31zx435hd
1 Oct 20
Submission of Matters to a Vote of Security Holders
4:09pm
CORRESP
sm0rozn9ox wbyije
28 Sep 20
Correspondence with SEC
12:00am
SEC STAFF
e6ao440n8 xvlfhh7d8
15 Sep 20
SEC staff action: Order
12:00am
UPLOAD
0uj4nxckmzoze35p
14 Sep 20
Letter from SEC
12:00am
8-K
9aq4mwe0yk7dwnz1 sc2
11 Sep 20
Departure of Directors or Certain Officers
4:17pm
424B3
jr8ymq9x40x zq
28 Aug 20
Prospectus supplement
4:31pm
EFFECT
1atowzhkbwq63
28 Aug 20
Notice of effectiveness
12:15am
CORRESP
8xz4qhby
25 Aug 20
Correspondence with SEC
12:00am